In 36% of cases, PI3K signaling is further dysregulated by phosphatase and tensin homolog (PTEN) deficiency (TCGA, 2008), whereas inactivation of the p53 and RB tumor suppressor pathways is characteristic of 87% and 78% of GBM tumors, respectively. The gene discussed is PTEN; the disease is neoplasm.